600056.SH
中国医药
SSE · Healthcare · Medical - Distribution · CN
CNY 9.17
−0.33%Year over year
Reported trailing growth
- Revenue
- +0.1%
- EBITDA
- —
- EBIT
- -0.1%
- EPS
- -20.8%
- Free cash flow
- +177.9%
- Operating cash flow
- +98.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -2.0%
- EBITDA
- -2.2%
- EBIT
- -5.2%
- Net income
- -13.7%
- EPS
- -13.7%
- Free cash flow
- -8.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026